AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis

Sponsored by St. Petersburg State Pavlov Medical University

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.

200

Target enrollment

Oct 2020

Start date

Dec 2026

Expected completion

Interventions / Treatments

Fludarabine Phosphate for Injection

Multiple Sclerosis

U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.

The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.